Page last updated: 2024-08-26

artesunic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

artesunic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernando, W; Greenshields, AL; Hoskin, DW	1

Other Studies

1 other study(ies) available for artesunic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells. Experimental and molecular pathology, 2019, Volume: 107 Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artesunate; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Humans; Receptor, ErbB-2; Triple Negative Breast Neoplasms	2019

Article

Year

The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.

Experimental and molecular pathology, 2019, Volume: 107

Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artesunate; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Humans; Receptor, ErbB-2; Triple Negative Breast Neoplasms

2019